Clopidogrel
- Product NDC
- 0615-7719
- 11-digit product format
- 006157719
- Labeler code
- 0615
- Product ID
- 0615-7719_ce3c1707-95ff-4004-961e-95e9bba43b5f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clopidogrel
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA076999
- Marketing category
- ANDA
- Marketing start
- 2012-05-17
- Marketing end
- 0000-00-00
- Substance
- CLOPIDOGREL BISULFATE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7719-05 | 2021-04-12 | C162847 | 48780-1 | 9d75b9d0-481f-f424-e053-dadaa90a57ce | c48f8ecc-291b-4e61-a4f2-338ecbbbf737 |
| 0615-7719-30 | 2021-04-12 | C162847 | 48780-1 | 9d75b9d0-481f-f424-e053-dadaa90a57ce | c48f8ecc-291b-4e61-a4f2-338ecbbbf737 |
| 0615-7719-39 | 2021-04-12 | C162847 | 48780-1 | 9d75b9d0-481f-f424-e053-dadaa90a57ce | c48f8ecc-291b-4e61-a4f2-338ecbbbf737 |
| 0615-7719-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-481f-f424-e053-dadaa90a57ce | c48f8ecc-291b-4e61-a4f2-338ecbbbf737 |
| 0615-7719-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-481f-f424-e053-dadaa90a57ce | c48f8ecc-291b-4e61-a4f2-338ecbbbf737 |
| 0615-7719-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-481f-f424-e053-dadaa90a57ce | c48f8ecc-291b-4e61-a4f2-338ecbbbf737 |